Chicago White Sox first baseman Jose Abreu has been dealing with tendinitis in his left ankle since spring training, but that didn't slow him down in April.
In fact, Abreu became the first player in American League history to win the Player of the Month and Rookie of the Month in the first month of his MLB career.
After leaving last night's game in the seventh inning, however, Abreu was placed on the 15-day disabled list today.
Back in Chicago, Abreu will get another MRI, but general manager Rick Hahn said "it's reasonable to believe" that Abreu will be back once his 15-day stint on the DL is up.
“I dislike speculating on return timeframes. ... as of right now, it’s reasonable to believe we’ll be able to resolve this thing within the 15-day period,” Hahn said, per Dan Hayes of CSN Chicago.
In a corresponding move, the White Sox activated Adam Eaton from the DL.
Abreu currently leads all of baseball in home runs (15) and trails only Miami's Giancarlo Stanton in runs batted in (42).
Showing posts with label Adam Eaton. Show all posts
Showing posts with label Adam Eaton. Show all posts
Sunday, May 18, 2014
Friday, March 22, 2013
Adam Eaton to miss 6-8 weeks with UCL sprain
Arizona Diamondbacks center fielder Adam Eaton will miss the next six to eight weeks with a left elbow UCL sprain, according to the team.
Expected to be the team's leadoff hitter, Eaton was hitting the ball really well this spring with his .390 average over 20 games.
"You know that I will work my butt off to get back in there," he tweeted. "It will be sooner than later."
Eaton is No. 73 on Baseball America's list of top 100 prospects and was No. 1 on Keith Law's list of Top 20 Impact Prospects for 2013.
Expected to be the team's leadoff hitter, Eaton was hitting the ball really well this spring with his .390 average over 20 games.
"You know that I will work my butt off to get back in there," he tweeted. "It will be sooner than later."
Eaton is No. 73 on Baseball America's list of top 100 prospects and was No. 1 on Keith Law's list of Top 20 Impact Prospects for 2013.
Subscribe to:
Posts (Atom)